SCHEMBL25045570

SCHEMBL25045570

CCP(CC)c1ccc(-n2ccn(/C(Nc3cc(C)c(F)c(C)c3)=C3\CN(C)CCC3=N)c2=O)c(F)c1NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23749729 0.64 — —
SCHEMBL24599387 0.58 — —
SCHEMBL23749856 0.54 GLP1R (0.36) —
SCHEMBL29177228 0.47 SOS1 (0.41) —
SCHEMBL17320328 0.46 HTT (0.50) —
SCHEMBL26739507 0.46 SOS1 (0.41) —
SCHEMBL13772553 0.45 NISCH (0.38) —
SCHEMBL6407111 0.44 SETD7 (0.54) —
SCHEMBL22993443 0.43 MAOA (0.46) —
SCHEMBL22993430 0.43 MAOA (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023016546-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2023-02-16 — — WO disclosed
Send feedback